Do We Have Good Reasons to Pay Bleeding Penalty With Lifelong Aspirin After LAAO?

Free article

Comment

Radoslaw Pracon et al. JACC Cardiovasc Interv. 2019.

Free article

. 2019 Sep 9;12(17):1741.

doi: 10.1016/j.jcin.2019.06.007.

No abstract available

Comment in

Reply: Do We Have Good Reasons to Pay Bleeding Penalty With Lifelong Aspirin After LAAO?
Saw J, Nielsen-Kudsk JE, Bergmann M, Daniels MJ, Tzikas A, Reisman M, Rana BS. Saw J, et al. JACC Cardiovasc Interv. 2019 Sep 9;12(17):1741-1742. doi: 10.1016/j.jcin.2019.07.005. JACC Cardiovasc Interv. 2019. PMID: 31488303 No abstract available.
Reply: Do We Have Good Reasons to Pay Bleeding Penalty With Lifelong Aspirin After LAAO?
Aminian A, Schmidt B, Nielsen-Kudsk JE. Aminian A, et al. JACC Cardiovasc Interv. 2019 Sep 9;12(17):1743. doi: 10.1016/j.jcin.2019.07.003. JACC Cardiovasc Interv. 2019. PMID: 31488304 No abstract available.

Antithrombotic Therapy and Device-Related Thrombosis Following Endovascular Left Atrial Appendage Closure.
Saw J, Nielsen-Kudsk JE, Bergmann M, Daniels MJ, Tzikas A, Reisman M, Rana BS. Saw J, et al. JACC Cardiovasc Interv. 2019 Jun 10;12(11):1067-1076. doi: 10.1016/j.jcin.2018.11.001. Epub 2019 May 15. JACC Cardiovasc Interv. 2019. PMID: 31103535 Review.
Incidence, Characterization, and Clinical Impact of Device-Related Thrombus Following Left Atrial Appendage Occlusion in the Prospective Global AMPLATZER Amulet Observational Study.
Aminian A, Schmidt B, Mazzone P, Berti S, Fischer S, Montorfano M, Lam SCC, Lund J, Asch FM, Gage R, Cruz-Gonzalez I, Omran H, Tarantini G, Nielsen-Kudsk JE. Aminian A, et al. JACC Cardiovasc Interv. 2019 Jun 10;12(11):1003-1014. doi: 10.1016/j.jcin.2019.02.003. Epub 2019 May 15. JACC Cardiovasc Interv. 2019. PMID: 31103540